ABT vs. FMS: Abbott Laboratories vs. Fresenius Medical Care Stock Comparison

Company Profile

Abbott Laboratories (ABT) and Fresenius Medical Care (FMS) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while FMS is classified in Health Care Providers & Services.

Abbott Laboratories (ABT) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Abbott Laboratories (ABT) at 9.14% and Fresenius Medical Care (FMS) at 7.84% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of Fresenius Medical Care (FMS) at 4.22%, which keeps about the industry-typical share.

Both Abbott Laboratories (ABT) at 11.66% and Fresenius Medical Care (FMS) at 9.63% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Abbott Laboratories (ABT) at 5.67% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Fresenius Medical Care (FMS) at 83.61% sits in the top EPS growth quartile, while Abbott Laboratories (ABT) at -51.31% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for FMS.

Both Abbott Laboratories (ABT) at 0.61 and Fresenius Medical Care (FMS) at 0.79 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Both Abbott Laboratories (ABT) at 2.22% and Fresenius Medical Care (FMS) at 6.30% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both Abbott Laboratories (ABT) at 92.54% and Fresenius Medical Care (FMS) at 50.14% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while Abbott Laboratories (ABT) at 41.02 is closer to its industry’s usual earnings multiple — a discount for FMS, though growth and earnings durability still matter.

Fresenius Medical Care (FMS) at 0.62 sits in the cheaper P/S ratio quartile while Abbott Laboratories (ABT) at 3.95 prices around its industry’s middle — FMS costs less per dollar of sales, though read it alongside growth and margins.

Fresenius Medical Care (FMS) at 0.85 sits in the lower P/B ratio quartile against book while Abbott Laboratories (ABT) at 3.73 is valued near its industry’s middle — FMS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics